Three-year safety and efficacy data for recombinant human parathyroid hormone, rhPTH(1-84), in the treatment of adults with hypoparathyroidism: the RACE study
2019 ◽
Vol 3
(Supplement_1)
◽
Keyword(s):
2017 ◽
Vol 39
(10)
◽
pp. 2096-2102
◽